Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 38 (4 Suppl 4), S26-36

Pharmacologic Options Available to Treat Symptomatic Intradialytic Hypotension

Affiliations
Review

Pharmacologic Options Available to Treat Symptomatic Intradialytic Hypotension

M A Perazella. Am J Kidney Dis.

Abstract

Treatment of symptomatic intradialytic hypotension (IDH) is a difficult task for the practicing nephrologist. Minimizing patient factors that precipitate IDH as well as dialysis procedure-related components that lower blood pressure are the initial approaches to this problem. However, despite these maneuvers, hypotension often persists in a group of high-risk patients. Pharmacologic interventions are often used to reduce IDH. Unfortunately, many of the available therapies are marginally effective and/or poorly tolerated. A few therapies appear to be efficacious and well tolerated-carnitine, sertraline, and midodrine. This article reviews the various pharmacologic therapies used for IDH and makes recommendations for treatment of this difficult problem.

Similar articles

See all similar articles

Cited by 5 PubMed Central articles

MeSH terms

LinkOut - more resources

Feedback